Favipiravir CAS 259793-96-9 T-705 Tsarkakewa

Favipiravir (T-705) (CAS 259793-96-9) yana ɗaya daga cikin mahadi guda 5 da WHO ta ba da shawarar don binciken maganin COVID-19.Favipiravir wani zaɓi ne mai hanawa na kwayar cutar RNA mai dogara da RNA polymerase tare da aiki akan ƙwayoyin cuta na RNA da yawa, ƙwayoyin mura, cutar ta West Nile, cutar zazzabin rawaya, ƙwayar cuta ta ƙafa-da-baki da sauran flaviviruses, arenaviruses, bunyaviruses da alphaviruses.Favipiravir babban magani ne na rigakafin ƙwayar cuta wanda Babban Jami'in Kula da Magunguna na Indiya (DCGI) ya share a makon da ya gabata don amfani da "ƙantacce na gaggawa" tsakanin marasa lafiya na Covid-19.Favipiravir ya samo asali ne a ƙarshen 1990s ta wani kamfani wanda kamfanin Japan Fujifilm ya saya daga baya a matsayin wani ɓangare na sauyawa daga kasuwancin hoto zuwa kiwon lafiya.Bayan an gwada shi akan nau'ikan ƙwayoyin cuta, an amince da maganin a Japan a cikin 2014 don amfani da gaggawa don rigakafin mura ko kuma magance sabbin nau'ikan mura.